Neudle.com: multiple sclerosis clinically isolated syndrome

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

adverse drug reaction

akinetic mute

algorithm

alternating rapid movement

amyloid angiopathy, cerebral

amyloid angiopathy, cerebral, inflammatory type

amyloid beta protein

amyloid beta-related angiitis

aneurysm

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiitis, isolated of CNS, benign focal

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, cerebral, false negative

angiography, cerebral, reversible abnormality

antibodies to myelin basic protein

antimyelin antibodies

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

basal ganglia, infarction

basal ganglia, lesion of

brain biopsy, false negative

brain volume

brainstem

brainstem, atrophy

brainstem, infarction of

brainstem, lesion of

bulbar palsy

calcium antagonist

Call-Fleming syndrome

carbamazepine

carbon monoxide poisoning

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, double dose

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, serial

central nervous system, infection of

central pontine myelinolysis

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellum

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral edema

cerebral edema, vasogenic

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, bilateral

cerebrovascular accident, familial occurrence

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, women

cervical spine

chasing the dragon

chemotherapy, CNS treatment and complications with

children

chin numbness

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

coma

complications

confusion

confusional state, acute

controversies in neurology

cop 1

corpus callosum

corpus callosum, lesion of

degenerative diseases of CNS

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dental procedure, neurologic complications with

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

dizziness

drug abuse

drug abuse, inhalation

drug abuse, neurologic complications of

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

endocarditis

epidemiology of neurology

Epstein-Barr virus

Erdheim-Chester disease

ethics in neurology

evoked potentials

extinction on double simultaneous stimulation

eye movement, disorders of

face, numbness of

facial weakness

facial weakness, bilateral

falling

familial

food-borne infection

fourth ventricle, shift of

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gastroenteritis

gaze palsy

gaze palsy, horizontal

gender

gene mutation

genetic neurologic disorders

gliomatosis cerebri

glutamic acid decarboxylase, antibody

granular osmiphilic material

granulomatous disease

headache, sudden onset of

headache, thunderclap

hearing loss

hearing loss, sudden, unilateral

heel-knee-shin test

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

herpes simplex virus

herpes virus

herpes zoster

herpes zoster, ophthalmicus

hiccoughs

histiocytosis

human immunodeficiency virus type 1

human immunodeficiency virus type 1, asymptomatic

hydrocephalus

hydrocephalus, exvacuo

hyperreflexia

hypersomnia

hypertensive encephalopathy

iatrogenic neurologic disorders

immunomodulation

immunosuppressive agents

incoordination

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intravenous

Jakob-Creutzfeldt disease

Kayser-Fleischer ring

laughing, pathologic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

level of consciousness, decreased

limbic encephalitis

listeria monocytogenes

lymphoma involving CNS

lymphoma, primary of CNS

MAGNIMS group

McDonald criteria for MS

medulla oblongata, lesion of

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis, aseptic

mental nerve

mental nerve neuropathy

mental status, abnormal

migraine

mimics

misdiagnosis

mitochondrial disease

MRI, angiography, false negative

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, incidental finding

MRI, snowball lesions

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, clinically isolated syndrome

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pain in

multiple sclerosis, paroxysmal symptoms in

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

nausea and vomiting

neoplasm, metastatic

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuroophthalmology

neuropathology

neuroprotective agents

Notch3 gene

numb chin syndrome

nystagmus

nystagmus, primary position of gaze

ocular bobbing

optic nerve, lesion of

optic neuritis

optic neuritis, etiology of

optic neuritis, treatment of

optical coherence tomography

optokinetic nystagmus(O.K.N.)

optokinetic nystagmus, abnormal

osteoblastic lesions, causes of

pain

pain, back

paraneoplastic cerebellar degeneration

Parkinsonism syndrome

paroxysmal neurologic deficits

PAS positive

PAS positive material in the brain

periventricular leukomalacia

personality change

phenylketonuria

pleocytosis of cerebrospinal fluid

pons, infarction of

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

psychiatric problems in neurologic disorders

pursuit eye movements, abnormal

pyramidal tract

pyramidal tract dysfunction

quadriparesis

quadriplegia

race

radiation therapy, CNS treatment and complications with

Rankin score

rapidly progressing neurologic illness

Red flags

rehabilitation for neurologic disorders

remote effect of cancer on the nervous system

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis factor(R.A.factor)

rigidity

risk factors

saccadic eye movements, abnormal

scotoma, paracentral-homonymous

sedimentation rate, elevated

seizure

sensorineural hearing loss

serologic testing

sickle cell disease

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spinal cord, cervical

spinal cord, ischemic lesion of

spinal cord, lesion of

standing difficulty

steroid

steroid therapy, CNS treatment and complications with

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

Susac's syndrome

symmetric brain lesions

symptomatic

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tandem gait, ataxic

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thyroiditis

tinnitus

tongue, impaired movements of

tonic spasms

toxic encephalopathy

treatment of neurologic disorder

tremor

trigeminal neuralgia

trigeminal neuropathy

trigeminal neuropathy, sensory

vasculitides

vasculopathy

vasoconstrictive drugs

vasospasm, cerebral

ventricular enlargement

visual evoked response

visual field defect

visual symptoms

walking, difficulty with

water channel antibodies

white matter disease, periventricular

work loss

workup

Showing articles 600 to 650 of 4597 << Previous Next >>

Past Adult Lead Exposure is Linked to Neurodegeneration Measured by Brain MRI
Neurol 66:1476-1484,1464, Stewart,W.F.,et al, 2006

Revised Diagnostic Criteria for Neuromyelitis Optica
Neurol 66:1485-1489, Wingerchuk,D.M.,et al, 2006

Community-Acquired Bacterial Meningitis in Adults
NEJM 354:44-53, van de Beek,D.,et al, 2006

Multiple Sclerosis in Twins From Continental Italy and Sardinia: A Nationwide Study
Ann Neurol 59:27-34, Ristori,G.,et al, 2006

Gray and White Matter Brain Atrophy and Neuropsychological Impairment in Multiple Sclerosis
Neurol 66:685-692, Sanfilipo,M.P.,et al, 2006

Cerebral Sinovenous Thrombosis in the Neonate
Arch Neurol 63:405-409, Fitzgerald,K.C.,et al, 2006

Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006

Diagnosis and Treatment of Multiple Sclerosis
BMJ 332:525-527, Murray,T.J., 2006

Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006

Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006

Metabolic Disease and Stroke: MELAS
emedicine.com, Mandava,P.,et al, 2006

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Multiple Sclerosis - The Plaque and Its Pathogenesis
NEJM 354:942-955, Frohman,E.M.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Diffusion-Weighted MR Imaging Characteristics of an Acute Strokelike Form of Multiple Sclerosis
AJNR 27:1006-1008, Rosso,C.,et al, 2006

Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005

Chasing "Chasing the Dragon" with MRI: Leukoencephalopathy in Drug Abuse
Br J Radiol 78:997-1004, Bartlett,E. &Mikulis,D.J., 2005

Unusual Presentation of Central Nervous System Cryptococcal Infection in an Immunocompetent Patient
AJNR 26:2522-2526, Saigal,G.,et al, 2005

Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005

MRI T2 Hypointensity of the Dentate Nucleus is Related to Ambulatory Impairment in Multiple Sclerosis
J Neurol Sci 234:17-24, Tjoa,C.W.,et al, 2005

Diffusion MRI in Multiple Sclerosis
Neurol 65:1526-1532, Rovaris,M.,et al, 2005

Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the "McDonald Criteria"
Ann Neurol 58:840-846, Polman,C.H.,et al, 2005

Pregnancy, Delivery, and Birth Outcome in Women with Multiple Sclerosis
Neurol 65:1961-1963, Dahl,J.,et al, 2005

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
Arch Neurol 62:1362-1365, Alonso,A.,et al, 2005

Pregnancy Outcomes During Treatment with Interferon Beta-1a in Patients with Multiple Sclerosis
Neurol 65:802-806, Sandberg-Wollheim,M.,et al, 2005

Randomized, Controlled Trial of Cannabis-Based Medicine in Central Pain in Multiple Sclerosis
Neurol 65:812-819,788, Rog,D.J.,et al, 2005

Whole-Body Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy
NEJM 353:1574-1584, Shankaran,S.,et al, 2005

Changes in the Ascertainment of Multiple Sclerosis
Neurol 65:1066-1070, Marrie,R.A.,et al, 2005

Acute Disseminated Encephalomyelitis
Arch Neurol 62:1673-1680, Menge,T.,et al, 2005

Bilateral Third Nerve Palsy and Temporal Arteritis
Arch Neurol 62:1766-1768, Lazaridis,C.,et al, 2005

Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005

Intractable Hiccup and Nausea With Pariaqueductal Lesions in Neuromyelitis Optica
Neurol 65:1479-1482, Misu,T.,et al, 2005

Triaging Transient Ischemic Attack and Minor Stroke Patients Using Acute Magnetic Resonance Imaging
Ann Neurol 57:848-854, Coutts,S.B.,et al, 2005

Recommended Standard of Cerebrospial Fluid Analysis in the Diagnosis of Multiple Sclerosis, A Consensus Statement
Arch Neurol 62:865-870, Freedman,M.S.,et al, 2005

Life-Threatening Acute Pancreatitis Associated with Interferon Beta-1a Treatment in Multiple Sclerosis
Neurol 65:170-171, Midgard,R.,et al, 2005

Vagal Nerve Stimulation Effect on Cerebellar Tremor in Multiple Sclerosis
Neurol 65:499, Marrosu,F.,et al, 2005

Polyneuropathy Associated with Interferon Beta Treatment in Patients with Multiple Sclerosis
Neurol 65:456-458, Ekstein,D.,et al, 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005

Primary Angiitis of the Central Nervous System: Emerging Variants
Q J Med 98:643-654, Maclaren,K.,et al, 2005

Neurologic and Developmental Disability at Six Years of Age After Extremely Preterm Birth
NEJM 352:9-19, 71, Marlow,N.,et al, 2005

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005

Modafinil for Fatigue in MS
Neurol 64:1139-1143, Stankoff,B.,et al, 2005

Anti-a4 Integrin Therapy for Multiple Sclerosis
Neurol 64:1336-1342, Rice,G.P.A.,et al, 2005

Migraine and Cerebral White Matter Lesions
The Neurologist 11:19-29, Gladstone,J.P. &Dodick,D.W., 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple Sclerosis
Arch Neurol 62:785-792, Schwid,S.R.,et al, 2005

Internuclear Ophthalmoplegia
Arch Neurol 62:714-717, Keane,J.R., 2005

Showing articles 600 to 650 of 4597 << Previous Next >>